Old drug with new application: spironolactone suppresses Panx 1-mediated Ca(2+) influx to attenuate inflammation-driven neutral lipid accumulation in early atherosclerosis.
- DOI
- 10.1007/s00011-026-02361-z
- Published
- 2026 Sep 14
- Container
- Inflammation research : official journal of the European Histamine Research Society ... [et al.]
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00011-026-02361-z,
title = {Old drug with new application: spironolactone suppresses Panx 1-mediated Ca(2+) influx to attenuate inflammation-driven neutral lipid accumulation in early atherosclerosis.},
author = {Yang Y and Gu T and Zheng M and Huang Q and Lu J and Chen J and Tang Y and Zhang X and Liao Y and Sun Y},
year = {2026},
journal = {Inflammation research : official journal of the European Histamine Research Society ... [et al.]},
doi = {10.1007/s00011-026-02361-z},
url = {https://doi.org/10.1007/s00011-026-02361-z}
}RIS
TY - JOUR TI - Old drug with new application: spironolactone suppresses Panx 1-mediated Ca(2+) influx to attenuate inflammation-driven neutral lipid accumulation in early atherosclerosis. AU - Yang Y AU - Gu T AU - Zheng M AU - Huang Q AU - Lu J AU - Chen J AU - Tang Y AU - Zhang X AU - Liao Y AU - Sun Y PY - 2026 JO - Inflammation research : official journal of the European Histamine Research Society ... [et al.] DO - 10.1007/s00011-026-02361-z UR - https://doi.org/10.1007/s00011-026-02361-z ER -
APA
Y, Y., T, G., M, Z., Q, H., J, L., J, C., Y, T., X, Z., Y, L., & Y, S. (2026). Old drug with new application: spironolactone suppresses Panx 1-mediated Ca(2+) influx to attenuate inflammation-driven neutral lipid accumulation in early atherosclerosis.. Inflammation research : official journal of the European Histamine Research Society ... [et al.]. https://doi.org/10.1007/s00011-026-02361-z
Source records
- pubmed · retrieved 2026-09-26T07:22:46.439Z
- europe-pmc · retrieved 2026-09-26T07:22:46.454Z